US Patent 7759357 Phenylpyrimidine amines as IgE inhibitors
Patent 7759357 was granted and assigned to Novartis on July, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+166 characters)
Article
Patent abstract
An amine, which is substituted by phenyl-substituted pyrimidin; and phenyl; and a third substituent and its use as an immunoglobulin E (IgE) inhibitor.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07759357 Phenylpyrimidine amines as IgE inhibitors US Patent 7759357 Phenylpyrimidine amines as IgE inhibitors
Infobox
Patent Number
0775935700
Patent Number
775935700
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077593570
Date of Patent
July 20, 2010
0Patent Application Number
118055150
Date Filed
May 23, 2007
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077593570
Date of Patent
July 20, 2010
0Patent Application Number
118055150
Date Filed
May 23, 2007
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07759357 Phenylpyrimidine amines as IgE inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07759357
Date of patent
July 20, 2010
Patent application number
11805515
Date Filed
May 23, 2007
Patent primary examiner
Find more entities like US Patent 7759357 Phenylpyrimidine amines as IgE inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
